Hua Jiang

2.8k total citations · 1 hit paper
54 papers, 2.0k citations indexed

About

Hua Jiang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hua Jiang has authored 54 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 19 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Hua Jiang's work include Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (8 papers) and Mesenchymal stem cell research (6 papers). Hua Jiang is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (8 papers) and Mesenchymal stem cell research (6 papers). Hua Jiang collaborates with scholars based in China, United States and United Kingdom. Hua Jiang's co-authors include Ruth J. Muschel, Yingqian Zhu, Qingqing Li, Rongbin Zhou, Jin‐Hui Tao, Xianming Deng, Hongbin He, Qingsong Liu, Jin Ye and Wei Huang and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Hua Jiang

54 papers receiving 2.0k citations

Hit Papers

Identification of a selec... 2017 2026 2020 2023 2017 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hua Jiang China 22 1.3k 508 279 270 233 54 2.0k
Wen Xu China 18 1.2k 0.9× 326 0.6× 375 1.3× 339 1.3× 179 0.8× 37 2.1k
Xiaofeng Wu China 24 899 0.7× 430 0.8× 456 1.6× 339 1.3× 202 0.9× 105 2.0k
Qing Chen China 26 1.1k 0.8× 313 0.6× 433 1.6× 115 0.4× 301 1.3× 112 2.4k
Rong Wang China 23 918 0.7× 368 0.7× 212 0.8× 176 0.7× 119 0.5× 88 1.6k
Jing Hao China 25 1.3k 1.0× 491 1.0× 293 1.1× 202 0.7× 260 1.1× 116 2.3k
Fei Zhao China 23 706 0.5× 298 0.6× 191 0.7× 366 1.4× 159 0.7× 98 1.7k
Shizhong Bu China 30 1.5k 1.2× 626 1.2× 298 1.1× 197 0.7× 270 1.2× 86 2.6k
Nicole L. Glazer United States 22 1.2k 0.9× 294 0.6× 230 0.8× 212 0.8× 495 2.1× 31 3.1k
Patricia B. Maguire Ireland 23 1.0k 0.8× 339 0.7× 310 1.1× 326 1.2× 263 1.1× 85 2.6k
Min Wu China 22 1.3k 1.0× 434 0.9× 113 0.4× 348 1.3× 237 1.0× 58 2.3k

Countries citing papers authored by Hua Jiang

Since Specialization
Citations

This map shows the geographic impact of Hua Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Jiang more than expected).

Fields of papers citing papers by Hua Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Jiang. The network helps show where Hua Jiang may publish in the future.

Co-authorship network of co-authors of Hua Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Hua Jiang. A scholar is included among the top collaborators of Hua Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua Jiang. Hua Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Jiawei, Zhipeng Cao, Gengming Niu, et al.. (2025). Clinical Significance of Acyl-CoA Dehydrogenase Short Chain and Its Anti-tumor Role in Hepatocellular Carcinoma by Inhibiting Canonical Wnt/β-Catenin Pathway. Digestive Diseases and Sciences. 70(2). 622–637. 1 indexed citations
2.
Zhang, Hongyi, Ming Yin, Jingwen Qin, et al.. (2025). Application of 4D‐Printed Magnetoresponsive FOGS Hydrogel Scaffolds in Auricular Cartilage Regeneration. Advanced Healthcare Materials. 14(9). e2404488–e2404488. 15 indexed citations
3.
4.
5.
Hu, Hao, Yuxin Qian, Xiaoyan Yu, et al.. (2022). Pyramidal multiple‐theory (multi‐type, multi‐method and multi‐layer) for facial fat grafting. Journal of Cosmetic Dermatology. 22(3). 937–944. 1 indexed citations
6.
Zhang, Ao, et al.. (2022). Circular RNA CircSLC8A1 contributes to osteogenic differentiation in hBMSCs via CircSLC8A1/miR‐144‐3p/RUNX1 in periprosthetic osteolysis. Journal of Cellular and Molecular Medicine. 27(2). 189–203. 4 indexed citations
7.
Zhu, Yingqian, et al.. (2021). Application of mesenchymal stem cell therapy for aging frailty: from mechanisms to therapeutics. Theranostics. 11(12). 5675–5685. 76 indexed citations
8.
Wang, Mengjie, Jun Shi, Hua Jiang, Kequn Xu, & Zhihui Huang. (2020). Circ_0014130 Participates in the Proliferation and Apoptosis of Nonsmall Cell Lung Cancer Cells via the miR-142-5p/IGF-1 Axis. Cancer Biotherapy and Radiopharmaceuticals. 35(3). 233–240. 23 indexed citations
9.
Ning, Yongling, Jun Ding, Xiao Sun, et al.. (2020). HDAC9 deficiency promotes tumor progression by decreasing the CD8+ dendritic cell infiltration of the tumor microenvironment. Journal for ImmunoTherapy of Cancer. 8(1). e000529–e000529. 30 indexed citations
10.
Zhu, Yingqian, et al.. (2020). Association between ambulatory blood pressure variability and frailty among older hypertensive patients. Journal of Clinical Hypertension. 22(9). 1703–1712. 17 indexed citations
11.
Shuai, You, Zhonghua Ma, Weitao Liu, et al.. (2020). TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2. Molecular Cancer. 19(1). 6–6. 105 indexed citations
12.
Zhang, Jiaqi, Hui Liu, Wenhao Zhang, et al.. (2020). Identification of lncRNA-mRNA Regulatory Module to Explore the Pathogenesis and Prognosis of Melanoma. Frontiers in Cell and Developmental Biology. 8. 615671–615671. 18 indexed citations
13.
Chen, Xin, Xi Zhou, Huan Li, Jinlan Li, & Hua Jiang. (2020). The value of WeChat application in chronic diseases management in China. Computer Methods and Programs in Biomedicine. 196. 105710–105710. 86 indexed citations
14.
Li, Qingqing, Shasha Geng, Yang Li, et al.. (2019). Circular RNA expression profiles in extracellular vesicles from the plasma of patients with pancreatic ductal adenocarcinoma. FEBS Open Bio. 9(12). 2052–2062. 25 indexed citations
15.
Chen, Xin & Hua Jiang. (2019). Tau as a potential therapeutic target for ischemic stroke. Aging. 11(24). 12827–12843. 28 indexed citations
16.
Shi, Jianwei, Rui Liu, Hua Jiang, et al.. (2018). Moving towards a better path? A mixed-method examination of China’s reforms to remedy medical corruption from pharmaceutical firms. BMJ Open. 8(2). e018513–e018513. 12 indexed citations
18.
He, Chengzhi, Hua Jiang, Shasha Geng, et al.. (2014). Expression and prognostic value of c-Myc and Fas (CD95/APO1) in patients with pancreatic cancer.. PubMed. 7(2). 742–50. 29 indexed citations
19.
Jiang, Hua, et al.. (2014). Doxorubicin induces drug resistance and expression of the novel CD44st via NF-κB in human breast cancer MCF-7 cells. Oncology Reports. 31(6). 2735–2742. 72 indexed citations
20.
Wang, Congjun, Ronghua Xu, Yongkun Wang, et al.. (2013). Bioinformatics Method to Analyze the Mechanism of Pancreatic Cancer Disorder. Journal of Computational Biology. 20(6). 444–452. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026